Contract award
EITR BIOLOGICS, INC.
THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE OVERALL OBJECTIVE OF THE WORK OUTLINED IN THIS CONTRACT IS TO CRITICALLY EVALUATE THE UTILITY OF THE VHH AS A PLATFORM MCM TECHNOLOGY FOR VI
- PIID
- 75A50123C00060
- Award key
- CONT_AWD_75A50123C00060_7505_-NONE-_-NONE-
- Recipient UEI
- HX49LZLY32G5
- Source as of
- Aug 6, 2026
Current award value
$33,059,6423
Obligated to date
$33,059,6422
Potential with options
$317,552,1353
- Awarding agency
- Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response
- Contractor
- EITR BIOLOGICS, INC.
- Place of performance
- San Diego, California
- Set-aside
- No set-aside used
- Pricing
- COST PLUS FIXED FEE
- Competition
- —1 offers received
- Period of performance
- Sep 22, 2023 — Sep 30, 2027Through Sep 30, 2034 if all options are exercised
- Benchmark category
- Unclassified
Transaction history
Every action recorded against this award, in the order the government reported them.
| Mod | Action date | Reason | Obligation | Value at action |
|---|---|---|---|---|
| 0 | Sep 22, 2023 | Initial award | $9,649,763.73 | $33,059,642.43 |
| P00001 | Dec 7, 2023 | B | $0.00 | $33,059,642.43 |
| P00002 | Mar 19, 2024 | G | $16,964,413.27 | $33,059,642.43 |
| P00003 | Jan 7, 2025 | B | $0.00 | $33,059,642.43 |
| P00004 | Jul 15, 2025 | B | $4,556,214.00 | $33,059,642.43 |
| P00005 | May 19, 2026 | B | $0.00 | $33,059,642.43 |
| P00006 | Jul 28, 2026 | SUPPLEMENTAL AGREEME | $1,889,251.43 | $33,059,642.43 |
Provenance
Which source record produced each displayed rollup figure.
| Field | Source | File | Retrieved | Parser | Artifact hash |
|---|---|---|---|---|---|
| awarding_agency_id | USAspending.gov | FY2026_All_Contracts_Full_20260807_1.csv | Sep 4, 2026 | usaspending_contract_csv@2026.08.2 | 24edb1916585 |
| contractor_id | USAspending.gov | FY2026_All_Contracts_Full_20260807_1.csv | Sep 4, 2026 | usaspending_contract_csv@2026.08.2 | 24edb1916585 |
| current_award_value | USAspending.gov | FY2026_All_Contracts_Full_20260807_1.csv | Sep 4, 2026 | usaspending_contract_csv@2026.08.2 | 24edb1916585 |
| naics_code | USAspending.gov | FY2026_All_Contracts_Full_20260807_1.csv | Sep 4, 2026 | usaspending_contract_csv@2026.08.2 | 24edb1916585 |
| potential_award_value | USAspending.gov | FY2026_All_Contracts_Full_20260807_1.csv | Sep 4, 2026 | usaspending_contract_csv@2026.08.2 | 24edb1916585 |
| psc_code | USAspending.gov | FY2026_All_Contracts_Full_20260807_1.csv | Sep 4, 2026 | usaspending_contract_csv@2026.08.2 | 24edb1916585 |
| total_obligated | USAspending.gov | FY2026_All_Contracts_Full_20260807_1.csv | Sep 4, 2026 | usaspending_contract_csv@2026.08.2 | 24edb1916585 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.
- 1Rollup values derive from 7 transaction records parsed from USAspending.gov (FY2026_All_Contracts_Full_20260807_1.csv), retrieved Sep 4, 2026 by transform awards@2026.08.1.
- 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
- 3Current and potential award values are taken from the latest reported action, not summed across modifications.